COLLINS PHARMACY (NOTTINGHAM) LIMITEDActive

Company number 01987703Private limited companyIncorporated 1986

Key figures

£337,125+5.3%
Net assets 2024/25
-32.4%
Average annual change 2019/20–2024/25
0500 k1 m1.5 m2 m2019/202020/212021/222023/242024/25

Like most small UK companies, COLLINS PHARMACY (NOTTINGHAM) LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Cash at bank and in hand1,182,5261,090,514168,382160,690131,460
Total assets1,919,3761,802,056731,438677,915720,320
Total liabilities302,611192,394———
Net assets / total equity1,616,7651,609,662461,196320,068337,125
Average number of employees1617171311

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: COLLINS PHARMACY (NOTTINGHAM) LIMITED

Company

COLLINS PHARMACY (NOTTINGHAM) LIMITED is a private limited company registered with Companies House under company number 01987703. It was incorporated on 10 Feb 1986. Its status is active. The registered office is in Leeds (LS3). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £337,125, up 5.3% on the previous year. Cash at bank and in hand was £131,460. The company had an average of 11 employees. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 3 of 9 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 20 Mar 2027.